Consistent with the previous anti-PD-1 screening, anti-PD-1 treatment induced significant tumor growth inhibition and significantly promoted survival in CT-26 tumor-bearing mice, but not in Colon 26 tumor-bearing animals (Fig. 1C and D, Additional file: Fig. S1). This evidence concerns the gene PDCD1 and neoplasm.